NBIX · Neurocrine Biosciences Inc · Fails to Deliver
$156.22
-0.35 (-0.22%)
At close · Sep 11
Market Cap
$15.88B
Shares
101.65M
Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.
Fails to Deliver History
| Settlement Date | Quantity | Price | Value |
|---|---|---|---|
| 2026-08-12 | 20 | $161.94 | $3,239 |
| 2026-08-07 | 1 | $159.82 | $160 |
| 2026-08-03 | 5,960 | $166.80 | $994,128 |
| 2026-07-29 | 33 | $182.83 | $6,033 |
| 2026-07-20 | 36 | $170.88 | $6,152 |
| 2026-07-09 | 382 | $178.24 | $68,088 |
| 2026-07-02 | 360 | $167.77 | $60,397 |
| 2026-06-25 | 201,605 | $166.06 | $33,478,526 |
| 2026-06-15 | 299 | $159.76 | $47,768 |
Showing 1–9 of 9 settlements
Key facts
CIK
914475
CUSIP
64125C109
13F (30d)
159 filings
157 filers
Visit website
Investor relations